Startseite>>Signaling Pathways>> Tyrosine Kinase>> Discoidin Domain Receptor>>DDR1-IN-1

DDR1-IN-1

Katalog-Nr.GC17365

DDR1-IN-1 ist ein potenter und selektiver DDR1-Rezeptor-Tyrosinkinase-Inhibitor mit einem IC50 von 105 nM; 4-fach weniger potent fÜr DDR2 (IC50 = 413 nM).

Products are for research use only. Not for human use. We do not sell to patients.

DDR1-IN-1 Chemische Struktur

Cas No.: 1449685-96-4

Größe Preis Lagerbestand Menge
10mM (in 1mL DMSO)
104,00 $
Auf Lager
5mg
85,00 $
Auf Lager
10mg
136,00 $
Auf Lager
50mg
612,00 $
Auf Lager
100mg
990,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com

Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

DDR1-IN-1 is a potent and selective DDR1 receptor tyrosine kinase inhibitor with an IC50 of 105 nM; 4-fold less potent for DDR2 (IC50 = 413 nM)[1].

DDR1-IN-1 effectively blocks collagen-induced DDR1 pY513 autophosphorylation in U2OS cells (EC50 = 86.76 nM) with excellent selectivity over a panel of >380 kinases. DDR1-IN-1 inhibits DDR2-mediated MT1-MMP activation in human rheumatoid synovial fibroblasts (RASF) upon collagen stimulation (IC50 < 2.5 μM) and enhances PI3K/mTOR inhibitor GSK2126458 antiproliferation efficacy in SNU-1040 colorectal cancer culture[1].

References:
[1]. Kim HG, et al. Discovery of a potent and selective DDR1 receptor tyrosine kinase inhibitor. ACS Chem Biol. 2013 Oct 18;8(10):2145-50.

Bewertungen

Review for DDR1-IN-1

Average Rating: 5 ★★★★★ (Based on Reviews and 36 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for DDR1-IN-1

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.